The Pharma Data

NOVEMBER 26, 2020

As drug molecules become more complex so do the options to deliver them. This novel nanoparticle formation technology provides hope for improving the possibilities and probabilities of developing better medicines for patients and it expands Nanoform’s reach into the growing biological market. HELSINKI , Nov. Finnish time.

Containment 52

Containment Medicine Development Bioavailability 52

The Pharma Data

DECEMBER 28, 2020

28, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“ BetterLife ” or the “ Company ”) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce that it has added Mr. Sergei Stetsenko to its Board of Directors to prepare for its growth phase in psychedelic medicines. VANCOUVER, Dec. BetterLife Pharma Inc.

Containment 52

Containment Drug Delivery Compliance Marketing 52

The Pharma Data

OCTOBER 20, 2020

“As a long-time watcher of TLC, I have observed improvements on all fronts and am impressed by the ripening pipeline and the efficiency of the development process of bringing life-changing medicines to patients. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Licensing 40

Licensing Licensing Drug Delivery Business Development 40

The Pharma Data

JANUARY 3, 2021

4, 2021 /PRNewswire/ — Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced a new near-term business target. Nanoform is an innovative nanoparticle medicine enabling company. HELSINKI , Jan. Finnish time. About Nanoform. For more information please visit [link].

Containment 40

Containment Bioavailability Clinical Trials Clinical Trials 40

The Pharma Data

JANUARY 25, 2021

Nasdaq: MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces a number of updates: 1. ” This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR). Q-Sphera Pipeline.

Containment 52

Containment Drug Delivery Licensing Licensing 52

Roots Analysis

JANUARY 17, 2024

They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. However, this needle system does not contain a proper locking system, therefore, increased the chances of leakage.

Drug Delivery 40

Drug Delivery Contamination Drugs Production 40

The Pharma Data

JANUARY 27, 2021

Further to XPhyto’s press release dated January 18, 2021, the Company’s core milestones for this year include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment in psychedelic medicine. About XPhyto Therapeutics Corp.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

The Pharma Data

JANUARY 3, 2021

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Except as required by law, TLC expressly disclaims any responsibility to update any forward-looking statement contained herein, whether as a result of new information, future events or otherwise.

Clinical Trials 52

Clinical Trials Clinical Trials Containment Development 52

The Pharma Data

JANUARY 27, 2021

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.

In-Vitro 52

In-Vitro Containment Drugs Production 52

The Pharma Data

JUNE 26, 2021

The PDS Marketing Authorisation Application has also been validated by the European Medicines Agency and is currently under review. 13 PDS contains a customised formulation of ranibizumab not approved by regulatory authorities. Portal is an extension study evaluating the long-term safety and efficacy of PDS in nAMD.

Drug Delivery 52

Drug Delivery Clinical Trials Clinical Trials Medicine 52

The Pharma Data

JANUARY 17, 2021

Following a successful business year 2020, XPhyto is well positioned to execute on important core milestones in all business divisions, which include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment and development in psychedelic medicine.

Production 40

Production Development Drug Delivery Drugs 40

The Pharma Data

DECEMBER 2, 2020

Progenity expects to use the net proceeds from the offering to support its operations, to invest in its molecular testing research and development program, to invest in research and development with respect to its precision medicine platform and for working capital and general corporate purposes. Progenity, Inc. Forward Looking Statements.

In-Vitro 40

In-Vitro Sales Containment Development 40

The Pharma Data

DECEMBER 2, 2020

is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity claim the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements.

Sales 40

Sales In-Vitro Containment Development 40

The Pharma Data

APRIL 27, 2021

A Minipump Continuous Drug Infusion Dog Model System to Identify Candidate Drugs and Drug Delivery Rates for Intracameral IOP-lowering Implants. A Retrospective Analysis: Visual Field Progression and Visual Acuity following Administration of Brimonidine Drug Delivery System. Sunday, May 2. Monday, May 3.

Research 40

Research Drug Delivery Systems Drug Delivery Production 40

The Pharma Data

MARCH 3, 2021

Mylan) and Kindeva Drug Delivery L.P. Symbicort (budesonide/formoterol) is a combination formulation containing budesonide, an inhaled corticosteroid that treats underlying inflammation, and formoterol, a long-acting beta2-agonist bronchodilator with a fast onset of action, in a single inhaler. Source link:[link].

Dermatology 52

Dermatology Drug Delivery Medicine Containment 52

Delveinsight

JANUARY 22, 2021

The drug provides an alternative to the current replacement of ADAMTS13 using large volumes of fresh frozen plasma that contain variable amounts of ADAMTS13 and typically require two hours or more for the preparation and infusion. According to the clinical trial website, the drug is in Phase III studies, but the status is unknown.

Marketing 65

Marketing Drugs Antibody Compliance 65

The Pharma Data

JANUARY 15, 2021

The submission was also reviewed under Project Orbis, an initiative of the FDA Oncology Center of Excellence, which provides a framework for concurrent submission and review of oncology medicine applications among international regulatory agencies. patients in gaining access to Darzalex Faspro® through the Janssen CarePath Savings Program.

FDA Approval 52

FDA Approval Production Research Development 52